We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+1.09%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
10 Year Est. Return
AUM
$5.6B
AUM Growth
+$69.6M
Cap. Flow
+$51.5M
Cap. Flow %
0.92%
Top 10 Hldgs %
21.06%
Holding
781
New
66
Increased
297
Reduced
239
Closed
62

Top Sells

Rank Stock Value
1
PII icon
Polaris
PII
+$36M
2
TROW icon
T. Rowe Price
TROW
+$31.5M
3
ELV icon
Elevance Health
ELV
+$27.8M
4
ITC
ITC HOLDINGS CORP
ITC
+$26.5M
5
AMAT icon
Applied Materials
AMAT
+$24.6M

Sector Composition

Rank Sector Weight
1 Healthcare 19.08%
2 Financials 18.2%
3 Consumer Discretionary 11.88%
4 Technology 11.08%
5 Industrials 10.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DDC
351
DELISTED
Dominion Diamond Corporation
DDC
$607K 0.01%
43,320
-580
-1% -$10.5K
FMBI
352
DELISTED
First Midwest Bancorp Inc/IL
FMBI
$606K 0.01%
31,946
RIO icon
353
Rio Tinto
RIO
$170B
$605K 0.01%
+14,690
New +$645K
ENH.PRA
354
DELISTED
ENDURANCE SPECIALTY HOLDINGS LTD PFD SER A
ENH.PRA
$603K 0.01%
23,500
-600
-2% -$15.6K
SWKS icon
355
Skyworks Solutions
SWKS
$10.1B
$593K 0.01%
5,695
+3,189
+127% +$323K
OGS icon
356
ONE Gas
OGS
$5B
$591K 0.01%
13,894
-219
-2% -$9.35K
DUK icon
357
Duke Energy
DUK
$94.2B
$590K 0.01%
8,361
+86
+1% +$6.5K
EOG icon
358
EOG Resources
EOG
$75.8B
$588K 0.01%
6,719
-901
-12% -$83.3K
AMJ
359
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$584K 0.01%
14,738
-6,000
-29% -$261K
BRFS
360
DELISTED
BRF SA
BRFS
$581K 0.01%
27,762
-1,804
-6% -$38.1K
IBB icon
361
iShares Biotechnology ETF
IBB
$10.8B
$581K 0.01%
4,725
+1,635
+53% +$196K
IHF icon
362
iShares US Healthcare Providers ETF
IHF
$1.24B
$576K 0.01%
20,150
+1,325
+7% +$35.9K
LNT icon
363
Alliant Energy
LNT
$17.7B
$568K 0.01%
19,698
+164
+0.8% +$4.97K
BAP icon
364
Credicorp
BAP
$29.6B
$558K 0.01%
4,016
-119
-3% -$17.4K
VRTX icon
365
Vertex Pharmaceuticals
VRTX
$139B
$557K 0.01%
4,507
-94,774
-95% -$11.9M
SWC
366
DELISTED
Stillwater Mining Co
SWC
$555K 0.01%
47,915
-310
-0.6% -$4.19K
NFX
367
DELISTED
Newfield Exploration
NFX
$554K 0.01%
15,335
-340
-2% -$12.6K
INDY icon
368
iShares S&P India Nifty 50 Index Fund
INDY
$551M
$553K 0.01%
18,530
+1,605
+9% +$48.4K
OMAB icon
369
Grupo Aeroportuario Centro Norte
OMAB
$4.96B
$546K 0.01%
13,901
+3,511
+34% +$140K
KALU icon
370
Kaiser Aluminum
KALU
$2.56B
$545K 0.01%
6,560
-350
-5% -$28.4K
AFL icon
371
Aflac
AFL
$58.4B
$542K 0.01%
17,428
+2,376
+16% +$75.2K
CHRD icon
372
Chord Energy
CHRD
$7.99B
$537K 0.01%
33,849
+438
+1% +$7.37K
ABEV icon
373
Ambev
ABEV
$44.4B
$530K 0.01%
86,858
-2,441
-3% -$15.1K
GIII icon
374
G-III Apparel Group
GIII
$1.41B
$529K 0.01%
7,520
-292
-4% -$17.9K
VEDL
375
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
$529K 0.01%
48,997
-2,566
-5% -$32.2K

Similar funds

Geneva Advisors's Q2 2015 Portfolio in Review

As of Q2 2015, Geneva Advisors held 781 positions worth $5.6B, up 1.3% from $5.53B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Geneva Advisors's Q2 2015 filing shows 66 new, 297 increased, 239 reduced and 62 closed positions. Its largest new stake was LinkedIn Corporation: 75,249 shares worth $15.5M. The largest sale was Polaris, an estimated $36M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Geneva Advisors's largest Q2 2015 buy was LinkedIn Corporation: 75,249 shares worth $15.5M.
  • Geneva Advisors added most to TD Ameritrade Holding Corp in Q2 2015, an estimated $41.7M increase.
  • Geneva Advisors's biggest Q2 2015 reduction was Polaris, cutting an estimated $36M.
  • Geneva Advisors fully exited Applied Materials in Q2 2015, selling an estimated $24.6M.
  • Geneva Advisors's ten largest holdings make up 21% of its $5.6B portfolio in Q2 2015.
  • Geneva Advisors opened 66 new positions and closed 62 in Q2 2015.
  • Geneva Advisors's portfolio value rose 1.3% quarter-over-quarter to $5.6B.

Based on Geneva Advisors's 13F filing for Q2 2015, filed 3 Aug 2015.